2 firms report vaccine solid in use for kids
Pfizer and its German partner BioNTech reported that their coronavirus vaccine is 91% effective in children 5-11 years old in documents posted Friday ahead of a meeting next week at which experts are scheduled to debate whether the shots are safe and effective.